CLSI M59
Epidemiological Cutoff Values for Antifungal Susceptibility Testing, 3rd Edition, M59Ed3E
standard by Clinical and Laboratory Standards Institute, 06/29/2020
CLSI NBS04
Newborn Screening by Tandem Mass Spectrometry, NBS04Ed2E
standard by Clinical and Laboratory Standards Institute, 05/01/2017
CLSI POCT17-Ed1
Use of Glucose Meters for Critically Ill Patients, 1st Edition, POCT17Ed1E
standard by Clinical and Laboratory Standards Institute, 03/29/2016
CLSI POCT13
Glucose Monitoring in Settings Without Laboratory Support; Approved Guideline, POCT13Ed3E
standard by Clinical and Laboratory Standards Institute, 06/01/2015
CLSI M27-S4
Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Fourth Informational Supplement, M27S4
standard by Clinical and Laboratory Standards Institute, 12/01/2012
CLSI H20-A2 (R2018)
Reference Leukocyte (WBC) Differential Count (Proportional) and Evaluation of Instrumental Methods; Approved Standard- Second Edition, H20-A2
standard by Clinical and Laboratory Standards Institute, 01/01/2007
CLSI AUTO16
Next-Generation In Vitro Diagnostic Instrument Interface, 1st Edition, AUTO16Ed1E
standard by Clinical and Laboratory Standards Institute, 04/23/2019
CLSI NBS05-A
Newborn Screening for Cystic Fibrosis; Approved Guideline (Formerly I/LA35-A), NBS05AE
standard by Clinical and Laboratory Standards Institute,
CLSI M51-A (R2018)
Method for Antifungal Disk Diffusion Susceptibility Testing of Filamentous Fungi; Approved Guideline, M51A
standard by Clinical and Laboratory Standards Institute, 01/01/2010
CLSI H54-A (R2018)
Procedures for Validation of INR and Local Calibration of PT/INR Systems; Approved Guideline, H54-A
standard by Clinical and Laboratory Standards Institute, 08/19/2005
CLSI C49-A
Analysis of Body Fluids in Clinical Chemistry; Approved Guideline, C49AE
standard by Clinical and Laboratory Standards Institute, 04/01/2007